Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PDG22 AS
AS
Active
Org 928999289
Hegdehaugsveien 36B, 0352 Oslo
Allmenn legetjeneste · NACE 86211
Est. 2022
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2023
NOK 0
EBITDA margin
—
-1983% vs 2022
Equity ratio
61.3%
Financial strength
Net profit 2023
NOK -10K
-2057% vs 2022
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
0%
2023
Key figures
Annual report 2023
Revenue
NOK 0
—
EBITDA
NOK -13K
-1983%
Net profit
NOK -10K
-2057%
Total assets
NOK 32K
+9%
Equity
NOK 20K
-33%
Employees
0
—
Company information
Legal name
PDG22 AS
Org number
928999289
Legal form
Aksjeselskap
NACE code
86211 · Allmenn legetjeneste
Founded
29. mars 2022
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Company purpose
Privatpraktiserende legekontor samt kjøp, salg og utleie av eiendom.
Contact
Address
Hegdehaugsveien 36B, 0352 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Allmenn legetjeneste
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
Income statement
NOK thousands
Item
2022
2023
Revenue
0
0
Staff expenses
−0
−0
EBITDA
−1
−12
Depreciation & amort.
−0
−0
EBIT
−1
−12
Net financials
0
0
Profit before tax
−1
−12
Tax
−0
−3
Net profit
−0
−10
Balance sheet
NOK thousands
Item
2022
2023
Total assets
30
32
Equity
30
20
Long-term debt
0
0
Short-term debt
0
13
Total debt
0
13
Financial ratios
5-year trend
EBITDA margin
-1250000.0%
This company
15.8%
Market median
-7911492% vs market
2022
2023
Equity ratio
61.3%
This company
38.2%
Market median
+60% vs market
2022
2023
Return on equity
-49.2%
This company
18.4%
Market median
-367% vs market
2022
2023
Net profit margin
-975000.0%
This company
8.1%
Market median
-12037137% vs market
2022
2023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2022
2023
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
2022
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-03-03 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
MT
Maya Tigalonova-Waliszewska
Board of Directors
2022
—
—
GT
Georg Tigalonov-Bjerke
Board of Directors
2022
—
—
JR
Jens Roar Bjerke
Chairman
2022
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Oslo Dermatology As
Company
100.0%
100.0%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Oslo Dermatology As
PDG22 AS
(this company)
Board network connections
Board members of PDG22 AS also hold positions in
0
other companies.
Person
Role here
Other companies
Maya Tigalonova-Waliszewska
Board of Directors
0 companies
Georg Tigalonov-Bjerke
Board of Directors
0 companies
Jens Roar Bjerke
Chairman
0 companies